Navigation Links
Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
Date:9/8/2010

of knowledge found nowhere else.  
  • Expansive Coverage: 50+ sessions (presentations, panel and roundtable discussions, and workshops) cover every important topic.

    • 2010 sponsors/exhibitors include:

    Fletcher/CSI, Deallus, Fuld & Company, Applied Intelligence, Aurora WDC, BCC Research, Best Practices, BioMedTracker, Brady Corp, Capital IQ, CBR Pharma Insights, Digimind, Dow Jones, dtw, Dunn Group, EvaluatePharma, Evalueserve, Financial Times, FirstWord, Indegene, Larvol Group, Lifescience Dynamics, MedPredict, Murray Hill Center, Northern Light, PharmaForce, PharmaVoxx, Prescient Life Sciences, Proactive Worldwide, research reporter, SAI MedPartners, Search Technology, Sedulo Group, ValueCentric, and Wolters Kluwer Pharma Solutions.  

    For more information or registration, go to www.Pharmaciconference.com, call 212.228.7974/713.398.6888 or email info@pharmaciconference.com.


    '/>"/>
    SOURCE Pharma CI Conference
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... Genetics, Inc. (NASDAQ: ATOS ), The Breast Health ... Chief Financial Officer & General Counsel, will present at the ... 2013, in New York City at ... is scheduled to begin at 3:30 p.m. EDT and will ... go to www.atossagenetics.com . For more information ...
    (Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
    (Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
    Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
    ... plc (LSE: SHP, Nasdaq: SHPGY ), the ... 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with ... at Digestive Disease Week, on May 31, 2009. Results ... patients, 20 percent of Lialda patients were continually persistent, ...
    ... , , KRX-0401 + Capecitabine More Than Doubles ... Extends Overall Survival vs. Capecitabine + Placebo in Patients ... , NEW YORK, June 1 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... activity of KRX-0401 (perifosine), the Company,s Akt-inhibitor for cancer, in ...
    Cached Medicine Technology:Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 2Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 3Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 4Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6
    (Date:5/18/2013)... SATURDAY, May 18 (HealthDay News) -- Children who swallow ... to remove the objects, according to a new study. ... Center in New Orleans, found that more than 79 ... required either surgery or an endoscopic procedure, in which ... digestive tract. Only 21 percent of these cases can ...
    (Date:5/18/2013)... published an original art book for iPad with tango as ... who share their creations based on the traditional music genre ... iPad . , This work gathers more than 150 ... signature idiosyncrasy and passion of tango. Such book is ... it includes a free trailer of the book for readers ...
    (Date:5/18/2013)... 2013) There are significant cost and risk ... diagnose or treat gastrointestinal problems, according to research ... A study by New York Presbyterian Hospital and ... may substantially reduce the cost and risk of ... believed to affect nearly 25 percent of adults, ...
    (Date:5/18/2013)... In a May 14, 2013 article entitled ... Discovering Cancer Gene,” Fox News reported the movie star ... she carried a gene that doctors estimated gave her ... 50 percent risk of ovarian cancer (go to: goo.gl/5JHBP). ... 2013 with a blog post entitled “A Patient’s Journey: ...
    (Date:5/18/2013)... A ground-breaking advance in colonoscopy technology signals ... presented today at Digestive Disease Week (DDW). Additional ... for colonoscopies and exploring safer methods for removing ... a device called a colonoscope to examine the ... a doctor to look for precancerous polyps called ...
    Breaking Medicine News(10 mins):Health News:Swallowing Magnets Can Be Fatal for Children 2Health News:New Art Book for iPad: Tango Art 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4
    ... Stockholm, Sweden: Melanoma of the eye (ocular or uveal melanoma) ... there is no effective treatment and patients die within an ... ten patients live for a year. Now, final results from ... significantly extends the time patients can live without the disease ...
    ... People,s bodies build up vitamin D through exposure to sunlight, ... areas of the United States with low sunlight are more ... in the same places. The researchers say the findings ... study shows that across-the-board vitamin D recommendations just won,t work ...
    ... FRIDAY, Sept. 23 (HealthDay News) -- Foreign-born U.S. women are ... cancer, but native-born women still outpace them, a new study ... mammography among foreign-born women in the United States, but there ... their use of recommended breast cancer screening," study lead researcher ...
    ... disabilities increased in the U.S. among non-elderly adults during ... Mojtabai, MD, PhD, of the Johns Hopkins Bloomberg School ... found the prevalence of disability attributed to other chronic ... remained unchanged. The findings will appear in the November ...
    ... A little motivation for parents could go a long ... their own care, a Wayne State University researcher believes. ... in WSU,s School of Medicine, has received a two-year, ... Digestive and Kidney Diseases of the National Institutes of ...
    ... News) -- Many people who undergo MRI scans describe feeling ... and a new study may explain why. Researchers ... on fluid circulating in the inner ear, impacting balance and ... , In the study, published online Sept. 22 in ...
    Cached Medicine News:Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 2Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 3Health News:Infusing chemotherapy into the liver gives extra months of disease-free life in melanoma patients 4Health News:Many Black Men in Cold Climates Lack Vitamin D 2Health News:Wayne State University study aims to improve diabetes management in high-risk youth 2Health News:Wayne State University study aims to improve diabetes management in high-risk youth 3Health News:Magnetic Field May Cause MRI-Induced Vertigo 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: